Jaime Bartushak - 11 Oct 2021 Form 4 Insider Report for Citius Pharmaceuticals, Inc. (CTXR)

Role: Chief Financial Officer
Signature: /s/ Alexander M. Donaldson, by power of attorney
Issuer symbol: CTXR
Transactions as of: 11 Oct 2021
Net transactions value: $0
Form type: 4
Filing time: 13 Oct 2021, 17:25:32 UTC
Previous filing: 26 Jul 2021
Next filing: 06 Oct 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	CTXR	Common Stock						60,353	11 Oct 2021	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CTXR	Stock Option (Right to Purchase Common Stock)	Award	$0	+300,000		$0.000000	300,000	11 Oct 2021	Common Stock	300,000	$2.04	Direct	F1
holding	CTXR	Stock Option (Right to Purchase Common Stock)						100,000	11 Oct 2021	Common Stock	100,000	$2.00	Direct	F2
holding	CTXR	Stock Option (Right to Purchase Common Stock)						125,000	11 Oct 2021	Common Stock	125,000	$1.01	Direct	F3
holding	CTXR	Stock Option (Right to Purchase Common Stock)						100,000	11 Oct 2021	Common Stock	100,000	$0.6700	Direct	F4
holding	CTXR	Stock Option (Right to Purchase Common Stock)						70,000	11 Oct 2021	Common Stock	70,000	$1.62	Direct	F5
holding	CTXR	Stock Option (Right to Purchase Common Stock)						25,000	11 Oct 2021	Common Stock	25,000	$3.45	Direct	F6
holding	CTXR	Stock Option (Right to Purchase Common Stock)						48,267	11 Oct 2021	Common Stock	48,267	$10.50	Direct	F7

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The options were granted on October 11, 2021. The options will vest 1/3 on each of the one-year, two-year and three-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company on each such vesting date.
F2	The options were granted on July 22, 2021. The options will vest 1/3 on each of the one-year, two-year and three-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company on each such vesting date.
F3	The options were granted on October 6, 2020. The options will vest 1/3 on each of the one-year, two-year and three-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company on each such vesting date
F4	The options were granted on October 8, 2019. The options will vest 1/3 on each of the one-year, two-year and three-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company on each such vesting date.
F5	One-third of the shares of the Company's common stock underlying the grant vest on each of the one-year, two-year and three-year anniversary of the Vesting Commencement Date, September 4, 2018, provided that the Optionee provides Continuous Service to the Company on each such vesting date.
F6	On September 15, 2017 the Reporting Person was granted a ten-year option to purchase 25,000 shares of common stock at an exercise price of $3.45 per share. The options vest as follows: 8,333 shares vest on September 13, 2018, and then 694 shares per month for the next 24 months.
F7	On July 6, 2016 the Reporting Person was granted a ten-year option to purchase 48,267 shares of common stock at an exercise price of $10.50 per share. The options vest as follows: 16,089 shares vest on July 7, 2017, and then 1,341 shares per month for the next 24 months.